Cécile Pautas Selected Research

Cécile Pautas Research Topics

Disease

22	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 05/2009
9	Leukemia 01/2020 - 10/2007
6	Infections 01/2020 - 01/2005
3	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2020 - 11/2008
3	Residual Neoplasm 03/2016 - 03/2013
3	Mycoses (Diseases, Fungus) 02/2011 - 04/2009
2	Toxoplasmosis 12/2019 - 01/2005
2	Thrombocytopenia (Thrombopenia) 01/2019 - 04/2012
2	Hematologic Neoplasms (Hematological Malignancy) 12/2017 - 04/2009
2	Invasive Fungal Infections 04/2009 - 02/2008
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2021
1	Measles 01/2020
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2019
1	Febrile Neutropenia 10/2018
1	Agranulocytosis (Granulocytopenia) 01/2018
1	Autoimmune Lymphoproliferative Syndrome 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Multiple Myeloma 12/2017
1	Lymphopenia (Lymphocytopenia) 06/2016
1	Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis) 04/2016
1	Hemolytic Anemia 07/2015
1	Hodgkin Disease (Hodgkin's Disease) 09/2013
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 05/2012
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2011
1	Pathologic Complete Response 06/2011
1	Blast Crisis (Blast Phase) 06/2011
1	Glioma (Gliomas) 08/2010
1	Chromosome Aberrations (Chromosome Abnormalities) 05/2009
1	Neoplasms (Cancer) 11/2008

Drug/Important Bio-Agent (IBA)

8	Gemtuzumab (Mylotarg)FDA Link 01/2021 - 01/2012
3	Core Binding Factors (Core-Binding Factor)IBA 06/2015 - 03/2013
3	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2013 - 06/2011
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2012 - 06/2011
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 08/2010
2	DNA (Deoxyribonucleic Acid)IBA 07/2015 - 01/2005
1	Conjugate VaccinesIBA 11/2020
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 11/2020
1	VaccinesIBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 12/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2018
1	Bortezomib (Velcade)FDA Link 12/2017
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 06/2016
1	Peroxidase (Myeloperoxidase)IBA 04/2016
1	Histocompatibility Antigens Class IIIBA 02/2016
1	AntibodiesIBA 02/2016
1	Viral AntibodiesIBA 07/2015
1	Immunoglobulin M (IgM)IBA 07/2015
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2015
1	Transcription Factors (Transcription Factor)IBA 06/2015
1	Dasatinib (BMS 354825)FDA Link 06/2015
1	alpha-hydroxyglutarateIBA 02/2014
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2013
1	trans-sodium crocetinate (crocetin)IBA 08/2011
1	Imatinib Mesylate (Gleevec)FDA Link 06/2011
1	Tyrosine Kinase InhibitorsIBA 06/2011
1	Protein Isoforms (Isoforms)IBA 08/2010
1	EnzymesIBA 08/2010
1	fms-Like Tyrosine Kinase 3IBA 05/2009
1	CCAAT-Enhancer-Binding Protein-alphaIBA 05/2009
1	galactomannanIBA 04/2009
1	AntigensIBA 04/2009
1	liposomal amphotericin B FDA Link 02/2008

Therapy/Procedure

11	Therapeutics 01/2021 - 01/2005
11	Drug Therapy (Chemotherapy) 01/2021 - 02/2011
6	Stem Cell Transplantation 01/2021 - 01/2005
5	Hematopoietic Stem Cell Transplantation 01/2021 - 12/2017
4	Cell Transplantation 01/2020 - 05/2012
2	Transplantation 01/2020 - 01/2005
1	Combination Drug Therapy (Combination Chemotherapy) 01/2018
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2013
1	Salvage Therapy 06/2012
1	Induction Chemotherapy 06/2011